J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding
Luis Ferrer-Barceló,Laura Sanchís Artero,Javier Sempere García-Argüelles,Pilar Canelles Gamir,Javier P. Gisbert,Luis Manuel Ferrer‐Arranz,Ana Monzó Gallego,Lydia Plana Campos,Jose Mª Huguet Malavés,Marisol Luján Sanchis,Lucía Ruiz Sánchez,Susana Barceló Cerdá,Enrique Medina Chuliá +12 more
TL;DR: Treatment guidelines for anaemia treatment guidelines for affected patients are lacking and iron deficiency anaemia is a common comorbidity.
Journal ArticleDOI
Su1171 Second-Line Rescue Triple Therapy With Levofloxacin After Failure of Non-Bismuth Quadruple “Sequential” or “Concomitant” Treatment to Eradicate H. pylori Infection
Javier P. Gisbert,Javier Molina-Infante,Alicia Marin,Gema Vinagre Rodriguez,Jesus Barrio,Adrian G. McNicholl +5 more
Journal ArticleDOI
Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.
María del Carmen R-Grau,María Chaparro,Francisco Mesonero,Manuel Barreiro-de Acosta,Luísa Castro,Manuel J. Castro,Eugeni Domènech,Noemí Manceñido,José Lázaro Pérez-Calle,Carlos Taxonera,Jesus Barrio,Ruth de Francisco,Estela Fernández-Salgado,Lara Luzón,Olga Merino,L. Oltra,Cristina Saro,Fernando Bermejo,Valle García-Sánchez,Daniel Ginard,Ana Gutiérrez,Isabel Vera,Rosario Anton,Yolanda Ber,Xavier Calvet,Javier P. Gisbert +25 more
TL;DR: Almost half of the patients achieved remission with a second anti-TNF after primary failure of the first, this strategy was less effective in patients with perianal disease.
Journal ArticleDOI
Seven-day versus 10- to 14-day therapies with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Hericobacter pylori infection. A metaanalysis
Journal ArticleDOI
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine.
David Laharie,Arnaud Bourreille,Julien Branche,Matthieu Allez,Yoram Bouhnik,Jérôme Filippi,Frank Zerbib,Guillaume Savoye,Lucine Vuitton,Jacques Moreau,Aurelien Amiot,Laurent Beaugerie,Elena Ricart,Olivier Dewit,Antonio López-Sanromán,Mathurin Fumery,Franck Carbonnel,Anthony Buisson,Benoit Coffin,Xavier Roblin,Gert Van Assche,Maria Esteve,Martti Färkkilä,Javier P. Gisbert,Philippe Marteau,Stéphane Nahon,Martine De Vos,Laurent Peyrin-Biroulet,Jean-Yves Mary +28 more
TL;DR: In steroid-refractory ASUC patients responding to a second-line medical therapy, endoscopic remission process started with bleeding remission and was not achieved in half the patients at day 98 for vascular pattern.